Simple, sensitive and rapid liquid chromatographic/electrospray ionization tandem mass spectrometric method for the quantification of lacidipine in human plasma

Journal of Mass Spectrometry

Volumn 39, Issue 7, 2004, Pages 824-832

  Ramakrishna, N V S ^a   Vishwottam, K N ^a   Puran, S ^a   Manoj, S ^a   Santosh, M ^a   Koteshwara, M ^a  

^a SUVEN LIFE SCIENCES LTD   (India)

Author keywords

Amlodipine; Lacidipine; Liquid chromatography electrospray ionization tandem mass spectrometry; Multiple reaction monitoring; Plasma

Indexed keywords

ACETONITRILE; CHROMATOGRAPHY; IONIZATION; LIGHT; MASS SPECTROMETRY; PH EFFECTS; PHARMACOKINETICS;

HUMAN PLASMA; LACIDIPINE;

LIQUID CHROMATOGRAPHY;

AMLODIPINE; AMMONIUM ACETATE; LACIDIPINE; TERT BUTYL METHYL ETHER; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE;

ACCURACY; ARTICLE; BLOOD SAMPLING; CALIBRATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG STABILITY; ELUTION; FREEZING; HUMAN; LIGHT EXPOSURE; LINEAR SYSTEM; LIQUID LIQUID EXTRACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SENSITIVITY ANALYSIS; TANDEM MASS SPECTROMETRY; TEMPERATURE SENSITIVITY; THAWING; TIME; VALIDATION PROCESS; BLOOD; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METHODOLOGY; SENSITIVITY AND SPECIFICITY;

CALCIUM CHANNEL BLOCKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIHYDROPYRIDINES; HUMANS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 4043152022     PISSN: 10765174     EISSN: None     Source Type: Journal    
DOI: 10.1002/jms.664     Document Type: Article

References (24)

1. Matrindale, The Extra Pharmacopeia (31st edn). Royal Pharmaceutical Society: London, 1996; 898.
2. Tcherdakoff P, Mallion JM, Rahn KH. French large-scale study evaluating the tolerability and efficacy of lacidipine. J. Cardiovasc. Pharmacol. 1995; 25: (Suppl. 3): S27.
3. Lee CR, Bryson HM. Lacidipine: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of hypertension. Drugs 1994; 48: 274.
4. McCormack PL, Wagstaff AJ. Lacidipine: a review of its use in the management of hypertension. Drugs 2003; 63: 2327.
5. Haller H, Cosentino F, Liischer TF. Endothelial dysfunction, hypertension and atherosclerosis: a review of the effects of lacidipine. Drugs R&D 2002; 3: 311.
6. Toniolo R, Narda FD, Bontempelli G, Ursini F. An electroanalytical investigation on the redox properties of lacidipine supporting its anti-oxidant effect. Bioelectrochemistry 2000; 51: 193.
7. Ros LD, Squassante L, Milleri S. Dose linearity of lacidipine pharmacokinetics after single and repeated oral doses in healthy volunteers. Clin. Pharmacokinet. 2003; 42: 99.
8. Pellegatti M, Braggio S, Sartori S. Validation of a high-performance liquid chromatographic - radioimmunoassay method for the determination of lacidipine in plasma. J. Chromatogr. 1992; 573: 105.
9. Braggio S, Sartori S, Angeri F, Pellegatti M. Automation and validation of the high-performance liquid chromatographic - radioimmunoassay method for the determination of lacidipine in plasma. J. Chromatogr. B 1995; 669: 383.
10. López JA, Martinez V, Alonso RM, Jiménez RM. High-performance liquid chromatography with amperometric detection applied to the screening of 1,4-dihydropyridines in human plasma. J. Chromatogr. A 2000; 870: 105.
11. Kharat VR, Verma KK, Dhake JD. Determination of lacidipine from urine by HPTLC using off-line SPE. J. Pharm. Biomed. Anal. 2002; 28: 789.
12. Rossato P, Scandola M, Grossi P. Investigation into lacidipine and related metabolites by high-performance liquid chromatography-mass spectrometry. J. Chromatogr. A 1993; 647: 155.
13. Evans GL, Ayrton J, Grossi P, Pellegatti M, Maltas J, Harkes AJ. An investigation of different analytical techniques for determining low levels of lacidipine in plasma. In Analysis of Drugs and Metabolites, Including Anti-infective Agents, Reid E, Wilson IA (eds). Cambridge: Royal Society of Chemistry: 1990; 285.
14. Dass C. Recent developments and applications of high-performance liquid chromatography - electrospray ionization mass spectrometry. Curr. Org. Chem. 1999; 3: 193.
15. Lee MS. LC/MS Applications in Drug Development. Wiley: New York, 2002.
16. Jemal M. High-throughput quantitative bioanalysis by LC-MS/MS. Biomed. Chromatqgr. 2000; 14: 422.
17. Ramakrishna NVS, Vishwottam KN, Puran S, Manoj M, Wishu S, Koteshwara M, Chidamabara J, Gopinadh B, Sumatha B. Liquid chromatography-negative ion electrospray tandem mass spectrometry method for the quantification of tacrolimus in human plasma and its bioanalytical applications. J. Chromatogr. 2004; 805: 13.
18. Macrae PV, Jones BC, Todd JFJ. Investigation of the metabolism of felodipine using on-line liquid chromatography/UV diode array detection/atmospheric pressure chemical ionization mass spectrometry as a diagnostic tool. Rapid Commun. Mass Spectrom. 1993; 7: 605.
19. Greenhill JV. Is the photodecomposition of drug predictable? In The Photostability of Drugs and Drug Formulations, Tonnesen HH (ed). Taylor and Francis: London, 1996; 83.
20. Albini A, Fasani E. Photochemistry of drugs: an overview and practical problems. In Drugs-Photochemistry and Photostability, Albini A, Fasani E (eds). Royal Society of Chemistry: Cambridge, 1998; 1.
21. Filippis P De, Bovina E, Ros L Da, Fiori J, Cavrini V. Photodegradation studies on lacidipine in solution: basic experiments with a cis-trans reversible photoequilibrium under UV-A radiation exposure. J. Pharm. Biomed. Anal. 2002; 27: 803.
22. Shah VP, Midha KK, Findlay JWA, Hill HM, Hulse JD, McGilveray IJ, Mckay G, Miller KJ, Patnaik RN, Powell ML, Tonelli A, Vishwanathan CT, Yacobi A. Bioanalytical method validation - a revisit with a decade of progress. Pharm. Res. 2000; 17: 1551.
23. Hartmann C, Pennickx W, Heyden YV, Vankerberghen P, Massart DL, McDowel RC, Blume HH, Midha KK. In Experience with Chromatographic Methods - Europe, in Bio-'94, Biointernational 2, Bioavailability, Bioequivalence and Pharmacokinetic Studies. Medpharm Scientific: Stuttgart, 1995; 331.
24. Guidance for Industry: Bioanalytical Method Validation. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research: Rockville, MD, 2001.